Literature DB >> 15817859

Effectiveness of selenium supplements in a low-selenium area of China.

Yiming Xia1, Kristina E Hill, Daniel W Byrne, Jiayuan Xu, Raymond F Burk.   

Abstract

BACKGROUND: Selenium is an essential micronutrient with a recommended dietary allowance for adults of 55 mug/d. It functions as an essential constituent of selenoproteins. Although there is no evidence of selenium deficiency in the United States, people in many other areas of the world are selenium deficient, with the consequence that they are unable to express their selenoproteins fully.
OBJECTIVE: We carried out a supplementation trial in a selenium-deficient population in China to assess the requirement for selenium as selenite and as selenomethionine.
DESIGN: One hundred twenty subjects with an average selenium intake of 10 mug/d were randomly assigned and administered tablets containing no selenium or amounts as high as 66 mug Se/d for 20 wk. Plasma was sampled before supplementation and at 4-wk intervals during supplementation and was assayed for the 2 plasma selenoproteins, glutathione peroxidase and selenoprotein P.
RESULTS: Full expression of glutathione peroxidase was achieved with 37 mug Se/d as selenomethionine and with 66 mug/d as selenite. Full expression of selenoprotein P was not achieved at the highest doses of either form.
CONCLUSIONS: Full expression of selenoprotein P requires a greater selenium intake than does full expression of plasma glutathione peroxidase. This suggests that selenoprotein P is a better indicator of selenium nutritional status than is glutathione peroxidase and that the recommended dietary allowance of selenium, which was set with the use of glutathione peroxidase as the index of selenium status, should be revised. Selenium as selenomethionine had nearly twice the bioavailability of selenium as selenite.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817859     DOI: 10.1093/ajcn/81.4.829

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  71 in total

1.  A Prospective Investigation of Graves' Disease and Selenium: Thyroid Hormones, Auto-Antibodies and Self-Rated Symptoms.

Authors:  Jan Calissendorff; Emil Mikulski; Erik H Larsen; Marika Möller
Journal:  Eur Thyroid J       Date:  2015-05-27

Review 2.  Selenium, selenoproteins and the thyroid gland: interactions in health and disease.

Authors:  Lutz Schomburg
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 3.  Selenoproteins and their impact on human health through diverse physiological pathways.

Authors:  Behzad Moghadaszadeh; Alan H Beggs
Journal:  Physiology (Bethesda)       Date:  2006-10

4.  Effect of hereditary haemochromatosis genotypes and iron overload on other trace elements.

Authors:  Jeffrey M Beckett; Madeleine J Ball
Journal:  Eur J Nutr       Date:  2012-02-09       Impact factor: 5.614

5.  Minimising the population risk of micronutrient deficiency and over-consumption: a new approach using selenium as an example.

Authors:  Andrew G Renwick; Lars O Dragsted; Reg J Fletcher; Albert Flynn; John M Scott; Sandra Tuijtelaars; T Wildemann
Journal:  Eur J Nutr       Date:  2008-01-14       Impact factor: 5.614

6.  Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

Authors:  Song Mao; Aihua Zhang; Songming Huang
Journal:  Endocrine       Date:  2014-05-25       Impact factor: 3.633

7.  Contrasting roles of dietary selenium and selenoproteins in chemically induced hepatocarcinogenesis.

Authors:  Marina V Kasaikina; Anton A Turanov; Andrei Avanesov; Ulrich Schweizer; Sandra Seeher; Roderick T Bronson; Sergey N Novoselov; Bradley A Carlson; Dolph L Hatfield; Vadim N Gladyshev
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

8.  Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.

Authors:  Matthew L Cooper; Hans-Olov Adami; Henrik Grönberg; Fredrik Wiklund; Fiona R Green; Margaret P Rayman
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 9.  Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements.

Authors:  Jolanta Gromadzińska; Edyta Reszka; Katharina Bruzelius; Wojciech Wasowicz; Björn Akesson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

10.  Higher selenium status is associated with adverse blood lipid profile in British adults.

Authors:  Saverio Stranges; Martin Laclaustra; Chen Ji; Francesco P Cappuccio; Ana Navas-Acien; Jose M Ordovas; Margaret Rayman; Eliseo Guallar
Journal:  J Nutr       Date:  2009-11-11       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.